Aducanumab addresses Alzheimer’s in a new way compared to currently approved drugs. This therapy slows progression of the disease, rather than only addressing symptoms. It is the first approved therapy of this type; it demonstrates that removing amyloid from the brain may delay clinical decline in people living with Alzheimer’s. Amyloid is the protein that clumps into sticky brain plaques that are a hallmark of Alzheimer’s disease.
First pallet to the White House.
Only $56K/year!!
Still cheaper than a nursing home room.
Just read a pretty disturbing story about this new drug.
https://arstechnica.com/science/2021/06/a-disgraceful-decision-researchers-blast-fda-for-approving-alzheimers-drug/?comments=1
Looks like there is very little proven about this drug and the FDA has really dropped the ball on this one.
You’re right, Jonnyv, even the company testing did not produce good results. I wonder what happened in the past 2 years? Better results? Bribes? Relaxing of standards?
Given what we’ve learned about the FedGov in the last 5 years, massive bribes would NOT surprise me at all.
Yes, the same FDA that said Hydroxychloroquine didn’t work and oops, a major study now says it helped the severely I’ll patients, when taken with zinc helped improve the chances of survival by 200%.
The FDA, media and Le Roi were wrong…again